Center for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Biomedical Sciences Graduate Program, The Ohio State University College of Medicine, Columbus, Ohio, USA.
Tissue Eng Part C Methods. 2023 Feb;29(2):72-84. doi: 10.1089/ten.TEC.2022.0189.
The advent of single-cell RNA sequencing (scRNA-Seq) has brought with it the ability to gain greater insights into the cellular composition of tissues and heterogeneity in gene expression within specific cell types. For tissue-engineered blood vessels, this is particularly impactful to better understand how neotissue forms and remodels into tissue resembling a native vessel. A notable challenge, however, is the ability to separate cells from synthetic biomaterials to generate high-quality single-cell suspensions to interrogate the cellular composition of our tissue-engineered vascular grafts (TEVGs) during active remodeling . We present here a simple, commercially available approach to separate cells within our TEVG from the residual scaffold for downstream use in a scRNA-Seq workflow. Utilizing this method, we identified the cell populations comprising explanted TEVGs and compared these with results from immunohistochemical analysis. The process began with explanted TEVGs undergoing traditional mechanical and enzymatic dissociation to separate cells from scaffold and extracellular matrix proteins. Magnetically labeled antibodies targeting murine origin cells were incubated with enzymatic digests of TEVGs containing cells and scaffold debris in suspension allowing for separation by utilizing a magnetic separator column. Single-cell suspensions were processed through 10 × Genomics and data were analyzed utilizing R to generate cell clusters. Expression data provided new insights into a diverse composition of phenotypically unique subclusters within the fibroblast, macrophage, smooth muscle cell, and endothelial cell populations contributing to the early neotissue remodeling stages of TEVGs. These populations were correlated qualitatively and quantitatively with immunohistochemistry highlighting for the first time the potential of scRNA-Seq to provide exquisite detail into the host cellular response to an implanted TEVG. These results additionally demonstrate magnetic cell isolation is an effective method for generating high-quality cell suspensions for scRNA-Seq. While this method was utilized for our group's TEVGs, it has broader applications to other implantable materials that use biodegradable synthetic materials as part of scaffold composition. Impact statement Single-cell RNA sequencing is an evolving technology with the ability to provide detailed information on the cellular composition of remodeling biomaterials . This present work details an effective approach for separating nondegraded biomaterials from cells for downstream RNA-sequencing analysis. We applied this method to implanted tissue-engineered vascular grafts and for the first time describe the cellular composition of the remodeling graft at a single-cell gene expression level. While this method was effective in our scaffold, it has broad applicability to other implanted biomaterials that necessitate separation of cell from residual scaffold materials for single-cell RNA sequencing.
单细胞 RNA 测序 (scRNA-Seq) 的出现使我们能够更深入地了解组织中的细胞组成和特定细胞类型中基因表达的异质性。对于组织工程血管,这对于更好地理解新组织如何形成并重塑为类似于天然血管的组织特别有意义。然而,一个显著的挑战是能够将细胞从合成生物材料中分离出来,以生成高质量的单细胞悬液,从而在我们的组织工程血管移植物 (TEVG) 进行主动重塑时,对其细胞组成进行分析。我们在这里介绍了一种简单的、商业上可用的方法,可将 TEVG 中的细胞与残留支架分离,以便在 scRNA-Seq 工作流程中进一步使用。利用这种方法,我们鉴定了从植入的 TEVG 中分离出来的细胞群体,并将这些结果与免疫组织化学分析的结果进行了比较。该过程从对植入的 TEVG 进行传统的机械和酶解分离开始,以将细胞与支架和细胞外基质蛋白分离。然后将针对鼠源性细胞的磁性标记抗体与含有细胞和支架碎片的 TEVG 酶解产物孵育,使细胞和支架碎片悬浮液通过磁性分离柱进行分离。单细胞悬液通过 10× Genomics 处理,然后利用 R 进行数据分析以生成细胞簇。表达数据提供了对 TEVG 早期新组织重塑阶段中纤维母细胞、巨噬细胞、平滑肌细胞和内皮细胞群体中表型独特亚群的多样化组成的新见解。这些群体在定性和定量上与免疫组织化学相关联,首次强调了 scRNA-Seq 提供对植入 TEVG 宿主细胞反应的详细信息的潜力。这些结果还表明,磁性细胞分离是一种有效的方法,可用于生成用于 scRNA-Seq 的高质量细胞悬浮液。虽然这种方法是我们小组用于 TEVG 的,但它具有更广泛的应用,可用于其他使用可生物降解的合成材料作为支架组成部分的可植入材料。 影响说明 scRNA-Seq 是一种不断发展的技术,具有提供关于重塑生物材料细胞组成的详细信息的能力。本工作详细介绍了一种有效的方法,可将未降解的生物材料与细胞分离,以便进行下游的 RNA 测序分析。我们将这种方法应用于植入的组织工程血管移植物,并首次在单细胞基因表达水平上描述了重塑移植物的细胞组成。虽然这种方法在我们的支架中很有效,但它具有广泛的适用性,可用于其他需要将细胞与残留支架材料分离以进行单细胞 RNA 测序的植入生物材料。